“On average, switching from one triptan to another or adding a second triptan is not helpful,” commented Dr. Lipton. “That is not to say that when we switch individual patients, there isn’t a benefit to that, or that optimized algorithms for choosing treatments have no effect on patient care.”
—Erik Greb
To read a commentary on this article, please click here.
To listen to an accompanying audiocast, please click here.